Skip to main content
. 2019 Jul 1;19:851. doi: 10.1186/s12889-019-6935-6

Table 5.

POAG prevalence by age and sex, 2010, AOK data

Age Prevalence (%), 95%-CI (Binomial Exact) Prevalent persons Persons on 01.01.2010
Males 50–54 0.84 (0.74–0.95)1 252 8.0% 29,949
55–59 1.38 (1.21–1.57) 227 7.2% 16,418
60–64 2.07 (1.83–2.33) 271 8.7% 13,090
65–69 3.27 (2.99–3.57) 473 15.1% 14,465
70–74 4.44 (4.13–4.77) 715 22.8% 16,102
75–79 5.32 (4.90–5.76) 562 17.9% 10,568
80–84 6.06 (5.49–6.66) 400 12.8% 6605
85–89 6.91 (5.98–7.93) 186 5.9% 2693
90+ 5.89 (4.34–7.78) 46 1.5% 781
Total 3132 110,671
Females 50–54 0.84 (0.73–0.95) 242 4.8% 28,932
55–59 1.58 (1.39–1.78) 264 5.2% 16,739
60–64 2.47 (2.21–2.74) 334 6.6% 13,538
65–69 3.83 (3.54–4.14) 614 12.2% 16,042
70–74 5.02 (4.72–5.33) 1007 20.0% 20,070
75–79 6.15 (5.80–6.52) 1043 20.7% 16,953
80–84 6.25 (5.85–6.66) 860 17.1% 13,770
85–89 5.49 (5.03–5.97) 510 10.1% 9296
90+ 4.04 (3.45–4.69) 161 3.2% 3989
Total 5035 139,329
Total 50–54 0.84 (0.77–0.92) 494 6.0% 58,881
55–59 1.48 (1.35–1.62) 491 6.0% 33,157
60–64 2.27 (2.10–2.46) 605 7.4% 26,628
65–69 3.56 (3.36–3.78) 1087 13.3% 30,507
70–74 4.76 (4.54–4.99) 1722 21.1% 36,172
75–79 5.83 (5.56–6.12) 1605 19.7% 27,521
80–84 6.18 (5.86–6.52) 1260 15.4% 20,375
85–89 5.81 (5.39–6.24) 696 8.5% 11,989
90+ 4.34 (3.78–4.96) 207 2.5% 4770
Total 8167 250,000